文献速递复苏、休克与脓毒症重症综合管理与镇静镇痛

星状神经节阻滞通过抑制自噬介导的血管平滑肌细胞表型转化逆转失血性休克肠系膜淋巴液诱导的血管低反应性

STELLATE GANGLION BLOCK REVERSES PHSML-INDUCED VASCULAR HYPOREACTIVITY THROUGH INHIBITING AUTOPHAGY-MEDIATED PHENOTYPIC TRANSFORMATION OF VSMCs.
PubMed 文献 · Shock · 2023-12-12
一句话结论大鼠实验显示,星状神经节阻滞通过抑制自噬介导的血管平滑肌细胞表型转化,改善失血性休克肠系膜淋巴液导致的血管低反应性。

该研究在清醒大鼠失血性休克模型中观察星状神经节阻滞(SGB)或静脉输注自噬抑制剂3-甲基腺嘌呤(3-MA)对肠道血流及肠系膜二级动脉组织自噬和表型定义蛋白表达的影响,并探讨腹腔给予失血性休克后肠系膜淋巴液(PHSML)及自噬激动剂雷帕霉素(RAPA)对SGB有益效应的影响。结果显示,失血性休克降低肠道血流并增强LC3 II/I、Beclin 1和基质金属蛋白酶2表达,SGB或3-MA可逆转这些变化,而RAPA和PHSML给药则消除SGB的有益效应。细胞实验进一步表明,PHSML(而非来自SGB处理大鼠的PHSML-SGB)孵育降低血管平滑肌细胞收缩力并诱导自噬激活和表型转化,3-MA可逆转PHSML的不良效应,RAPA则减弱PHSML-SGB对血管平滑肌细胞的作用。作者认为,SGB的保护作用是通过抑制过度自噬介导的血管平滑肌细胞表型转化、维持其收缩表型实现的。

要点

  • 失血性休克大鼠肠道血流下降,肠系膜二级动脉LC3 II/I、Beclin 1和基质金属蛋白酶2表达增强,SGB或静脉输注3-MA可逆转这些变化。
  • 腹腔给予PHSML或自噬激动剂RAPA可消除SGB对失血性休克大鼠肠道血流和自噬相关蛋白的有益效应。
  • PHSML孵育降低血管平滑肌细胞收缩力并诱导自噬激活和表型转化,而PHSML-SGB无此效应;3-MA可逆转PHSML的不良效应。
  • RAPA处理可减弱PHSML-SGB孵育对血管平滑肌细胞的作用。
  • 作者结论:SGB通过抑制过度自噬介导的血管平滑肌细胞表型转化、维持收缩表型来保护血管反应性。

适用人群与场景

  • 清醒大鼠失血性休克模型;肠系膜二级动脉组织及血管平滑肌细胞

处置流程与药物剂量

  • 星状神经节阻滞(SGB)干预或静脉输注自噬抑制剂3-甲基腺嘌呤(3-MA)可逆转失血性休克引起的肠道血流下降及LC3 II/I、Beclin 1、基质金属蛋白酶2表达增强。
  • 腹腔给予PHSML或自噬激动剂雷帕霉素(RAPA)可消除SGB的有益效应。
  • 体外实验中,3-MA给药可逆转PHSML对血管平滑肌细胞的不良效应;RAPA处理可减弱PHSML-SGB孵育对血管平滑肌细胞的作用。

研究设计与关键结果

  • 研究类型:大鼠在体及细胞实验;样本量原文未报告。
  • 失血性休克降低肠道血流并增强肠系膜二级动脉LC3 II/I、Beclin 1和基质金属蛋白酶2表达,SGB或3-MA治疗可逆转。
  • 腹腔给予PHSML或RAPA可消除SGB的有益效应。
  • PHSML(而非PHSML-SGB)孵育降低血管平滑肌细胞收缩力并诱导自噬激活和表型转化;3-MA可逆转PHSML的不良效应,RAPA可减弱PHSML-SGB孵育对血管平滑肌细胞的作用。

证据类型、等级与局限

  • 证据类型:动物实验(大鼠在体及细胞实验)。
  • 局限:原文未报告局限性

对床旁实践的改变

  • 原文为动物实验,作者认为SGB的保护作用是通过抑制过度自噬介导的血管平滑肌细胞表型转化、维持收缩表型实现的。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

Posthemorrhagic shock mesenteric lymph (PHSML) return-contributed excessive autophagy of vascular smooth muscle cells (VSMCs) is involved in vascular hyporeactivity, which is inhibited by stellate ganglion block (SGB) treatment. The contractile phenotype of VSMCs transforms into a synthetic phenotype after stimulation with excessive autophagy. Therefore, we hypothesized that SGB ameliorates PHSML-induced vascular hyporeactivity by inhibiting autophagy-mediated phenotypic transformation of VSMCs. To substantiate this hypothesis, a hemorrhagic shock model in conscious rats was used to observe the effects of SGB intervention or intravenous infusion of the autophagy inhibitor 3-methyladenine (3-MA) on intestinal blood flow and the expression of autophagy- and phenotype-defining proteins in mesenteric secondary artery tissues. We also investigated the effects of intraperitoneal administration of PHSML intravenous infusion and the autophagy agonist rapamycin (RAPA) on the beneficial effect of SGB. The results showed that hemorrhagic shock decreased intestinal blood flow and enhanced the expression of LC3 II/I, Beclin 1, and matrix metalloproteinase 2, which were reversed by SGB or 3-MA treatment. In contrast, RAPA and PHSML administration abolished the beneficial effects of SGB. Furthermore, the effects of PHSML or PHSML obtained from rats treated with SGB (PHSML-SGB) on cellular contractility, autophagy, and VSMC phenotype were explored. Meanwhile, the effects of 3-MA on PHSML and RAPA on PHSML-SGB were observed. The results showed that PHSML, but not PHSML-SGB, incubation decreased VSMC contractility and induced autophagy activation and phenotype transformation. Importantly, 3-MA administration reversed the adverse effects of PHSML, and RAPA treatment attenuated the effects of PHSML-SGB incubation on VSMCs. Taken together, the protective effect of SGB on vascular reactivity is achieved by inhibiting excessive autophagy-mediated phenotypic transformation of VSMCs to maintain their contractile phenotype.

来源:Shock,查看原文。版权归原作者所有。

参考来源

  1. Li CJ, Du HB, Zhao ZA, et al. STELLATE GANGLION BLOCK REVERSES PHSML-INDUCED VASCULAR HYPOREACTIVITY THROUGH INHIBITING AUTOPHAGY-MEDIATED PHENOTYPIC TRANSFORMATION OF VSMCs. Shock. 2023. PMID: 38150357. doi:10.1097/SHK.0000000000002289

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。